How obesity drives colon cancer in mice

July 4, 2018 by Ziba Kashef, Yale University
Credit: (c) stock.adobe.com

Obesity, which is on the rise worldwide, has been linked to colon cancer but the mechanism has been a mystery. In a new study, Yale researchers and their co-authors have uncovered how obesity drives tumor growth in mice, revealing potential strategies to combat the disease.

Led by assistant professor Rachel Perry, the research team studied with either implanted tumors or a genetic model of . The researchers first examined the effects of a high-fat diet on the mice. Then they gave the mice one of two medications: either a drug that burns fat in the liver by acting as a controlled-release mitochondrial protonophore (CRMP), or metformin, the most commonly prescribed drug for diabetes worldwide.

The research team found that high levels of insulin was the link between obesity and colon cancer, Perry said. Insulin increases the uptake of glucose in tumors, driving . The researchers also discovered that both drugs reduced and slowed tumor growth in the mice.

"This study is the first to prove that high insulin levels resulting from obesity drive colon cancer by increasing glucose uptake in these models," said Perry. While further research is needed to confirm if the findings apply to humans, the implication is that insulin-reducing therapies—either metformin, CRMP, or even exercise—could help slow or prevent colon cancer.

Explore further: Metformin could one day be used to treat malignant tumors

More information: Yongliang Wang et al. Uncoupling Hepatic Oxidative Phosphorylation Reduces Tumor Growth in Two Murine Models of Colon Cancer, Cell Reports (2018). DOI: 10.1016/j.celrep.2018.06.008

Related Stories

Metformin could one day be used to treat malignant tumors

January 16, 2018
A*STAR researchers have provided strong evidence, using patient tumor grafts, that metformin, a common diabetes drug, might help fight colorectal cancer in humans.

Culprit in reducing effectiveness of insulin identified

April 26, 2018
Scientists at Osaka University have discovered that Stromal derived factor-1 (SDF-1) secreted from adipocytes reduces the effectiveness of insulin in adipocytes and decreased insulin-induced glucose uptake.

Study suggests colon cancer cells carry bacteria with them when they metastasize

November 24, 2017
(Medical Xpress)—A team of researchers working at Harvard University has found evidence that suggests a certain type of bacteria found in colon cancer tumors makes its way to tumors in other body parts by traveling with ...

Study could explain link between high-cholesterol diet and colon cancer

January 25, 2018
New UCLA research could help explain the link between a high-cholesterol diet and an elevated risk for colon cancer.

Fat reduction did not reduce incidence of colon and liver tumors in mouse studies

November 4, 2016
Losing weight may not protect against colon and liver cancer, even though obesity is associated with increased risk of certain types of gastrointestinal malignancy. Researchers from the University of South Carolina found ...

New compounds increase glucose uptake into fat cells

February 20, 2017
New molecules which scientists hope could one day become drugs for both cancer and diabetes have been created at the University of Bath.

Recommended for you

Pancreatic cancer's addiction could be its end

November 13, 2018
Cancer cells are often described as cells "gone bad" or "renegade." New research reveals that in some of the deadliest cases of pancreatic cancer, these rebellious cells have an unexpected addiction. Now, scientists are investigating ...

Cognitive decline—radiation—brain tumor prevented by temporarily shutting down immune response

November 13, 2018
Treating brain tumors comes at a steep cost, especially for children. More than half of patients who endure radiation therapy for these tumors experience irreversible cognitive decline, a side-effect that has particularly ...

Study finds promising therapeutic target for aggressive type of breast cancer

November 13, 2018
A new Nature Communications study led by University of Kentucky Markey Cancer Center researchers suggests that an enzyme known as Prolyl 4-hydroxylase subunit alpha-1 (P4HA1) is a potential therapeutic target for triple negative ...

Solving the mystery of NPM1 in acute myeloid leukemia

November 13, 2018
Although it has long been recognized that mutations of gene NPM1 play an important role in acute myeloid leukemia, no one has determined how the normal and the mutated forms of the protein NPM1 function.

Scientists shine new light on link between obesity and cancer

November 12, 2018
Scientists have made a major discovery that shines a new, explanatory light on the link between obesity and cancer. Their research confirms why the body's immune surveillance systems—led by cancer-fighting Natural Killer ...

Obesity both feeds tumors and helps immunotherapy kill cancer

November 12, 2018
A groundbreaking new study by UC Davis researchers has uncovered why obesity both fuels cancer growth and allows blockbuster new immunotherapies to work better against those same tumors.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.